[go: up one dir, main page]

RU93051783A - METHOD OF DETECTION OF IMPROVEMENT - Google Patents

METHOD OF DETECTION OF IMPROVEMENT

Info

Publication number
RU93051783A
RU93051783A RU93051783/14A RU93051783A RU93051783A RU 93051783 A RU93051783 A RU 93051783A RU 93051783/14 A RU93051783/14 A RU 93051783/14A RU 93051783 A RU93051783 A RU 93051783A RU 93051783 A RU93051783 A RU 93051783A
Authority
RU
Russia
Prior art keywords
syndecan
improvement
detection
biological material
comparing
Prior art date
Application number
RU93051783/14A
Other languages
Russian (ru)
Other versions
RU2139540C1 (en
Inventor
Тапани Ялканен Маркку
Лена Кюлликки Инки Пирьо
Кирьявайнен Яркко
Марианне Леппя Сирпа
Маркку Мали Сакари
Original Assignee
Тапани Ялканен Маркку
Лена Кюлликки Инки Пирьо
Кирьявайнен Яркко
Марианне Леппя Сирпа
Маркку Мали Сакари
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тапани Ялканен Маркку, Лена Кюлликки Инки Пирьо, Кирьявайнен Яркко, Марианне Леппя Сирпа, Маркку Мали Сакари filed Critical Тапани Ялканен Маркку
Priority claimed from PCT/FI1991/000399 external-priority patent/WO1992013274A1/en
Publication of RU93051783A publication Critical patent/RU93051783A/en
Application granted granted Critical
Publication of RU2139540C1 publication Critical patent/RU2139540C1/en

Links

Claims (1)

Предложен способ обнаружения потенциально неблагоприятных трансформаций клеток в организме. Этот способ заключается в определении количества синдикана в образце биологического материала, взятого из организма, и сравнении указанного определенного количества синдикана с эталонным количеством синдикана, полученным из эталонного биологического материала того же типа.A method is proposed for detecting potentially adverse cell transformations in the body. This method consists in determining the amount of syndecan in a sample of biological material taken from the body, and comparing the specified quantity of syndecan with a reference quantity of syndecan obtained from reference biological material of the same type.
RU93051783/14A 1991-01-15 1991-12-19 Method of detection of malignancy RU2139540C1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US64120991A 1991-01-15 1991-01-15
FI641209 1991-01-15
US641,209 1991-01-15
US72133091A 1991-07-01 1991-07-01
FI721330 1991-07-01
US721,330 1991-07-01
PCT/FI1991/000399 WO1992013274A1 (en) 1991-01-15 1991-12-19 Detection of syndecan content in biological materials such as tissues and body fluids for indications of malignant transformations of cells

Publications (2)

Publication Number Publication Date
RU93051783A true RU93051783A (en) 1996-05-10
RU2139540C1 RU2139540C1 (en) 1999-10-10

Family

ID=27093707

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93051783/14A RU2139540C1 (en) 1991-01-15 1991-12-19 Method of detection of malignancy

Country Status (23)

Country Link
US (1) US5422243A (en)
EP (2) EP0816851A3 (en)
JP (1) JP3103377B2 (en)
KR (1) KR0162670B1 (en)
AT (1) ATE166157T1 (en)
AU (1) AU650936B2 (en)
BG (1) BG61625B1 (en)
CA (1) CA2100077C (en)
CZ (1) CZ282203B6 (en)
DE (1) DE69129417T2 (en)
DK (1) DK0569367T3 (en)
ES (1) ES2116331T3 (en)
FI (1) FI104347B1 (en)
HU (1) HU215778B (en)
IE (2) IE920107A1 (en)
NO (1) NO314604B1 (en)
NZ (1) NZ241273A (en)
PL (1) PL168188B1 (en)
PT (1) PT100008B (en)
RU (1) RU2139540C1 (en)
SK (1) SK281583B6 (en)
WO (1) WO1992013274A1 (en)
ZA (1) ZA92271B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU687767B2 (en) * 1992-12-01 1998-03-05 Oy Biotie Therapies Ltd Syndecan stimulation of cellular differentiation
US5726058A (en) * 1992-12-01 1998-03-10 Jalkanen; Markku Syndecan stimulation of cellular differentiation
US6017727A (en) * 1994-03-07 2000-01-25 Biotie Therapies Ltd. Syndecan enhancer element and syndecan stimulation of cellular differentiation
US5851993A (en) * 1994-06-13 1998-12-22 Biotie Therapies Ltd. Suppression of tumor cell growth by syndecan-1 ectodomain
GB9519490D0 (en) * 1995-09-25 1995-11-29 Melvin William T Use of a cytochrome P450 enzyme in tumour cells as a marker and target
US6385546B1 (en) 1996-11-15 2002-05-07 Rutgers, The University Of New Jersey Stabilizing and destabilizing proteins
JP4287588B2 (en) * 1997-08-12 2009-07-01 レアト ベー．フェー． Quantification of transforming ability of agents
CA2346264A1 (en) * 1998-10-16 2000-04-27 Regents Of The University Of California Glypicans for the detection and treatment of human carcinoma
RU2169922C1 (en) * 1999-02-12 2001-06-27 Трушин Алексей Иванович Method and device for diagnosing proliferation areas
US6998232B1 (en) * 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
WO2001077682A1 (en) * 2000-04-10 2001-10-18 Institut Bioorganicheskoi Khimii Imeni Akademikov M.M. Shemyakina I Ju. A. Ovchinnikova Rossiisskoi Akademii Nauk Antibodies directed against the hldf factor, methods for production thereof, peptide provided with antigenic and hk-hydrolizing properties and method for diagnosing an anaplastic condition of a human cell
AU2002338431A1 (en) * 2001-04-04 2002-11-05 Quark Biotech, Inc. Sequence characteristics of bladder cancer
RU2279089C1 (en) * 2004-11-17 2006-06-27 Государственное учреждение Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского (МОНИКИ им. М.Ф. Владимирского) Differential diagnosis method for determining squamous cell skin carcinoma and keratoacanthoma cases
KR100694804B1 (en) * 2005-05-18 2007-03-14 아주대학교산학협력단 A composition for treating or preventing endometrial cancer comprising a small hairpin RNA molecule and a method for treating or preventing endometrial cancer using the same
US8347890B2 (en) * 2006-06-19 2013-01-08 Insono Therapeutics, Inc. Automated tissue retention system
US20090220588A1 (en) * 2008-02-21 2009-09-03 Massachusetts Institute Of Technology Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity
GB0803272D0 (en) * 2008-02-22 2008-04-02 Smith & Nephew Ultrasound and tissue repair

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2560996B1 (en) * 1984-03-09 1988-01-15 Commissariat Energie Atomique IMMUNOLOGICAL ASSAY PROCESS FOR ANTIGENS, ANTIBODIES OR HAPTENES, USE THEREOF FOR ASSAYING LIPOPROTEINS AND A-FOETOPROTEIN AND ASSAY KITS FOR CARRYING OUT SAID METHOD
DE3511199A1 (en) * 1985-03-28 1986-10-02 Hoechst Ag, 6230 Frankfurt METHOD FOR THE IMMUNOLOGICAL DETERMINATION OF HEPARANESULFATE PROTEOGLYCANE, METHOD FOR THE PRODUCTION OR CLEANING OF SUITABLE HEPARANESULFATE PROTEOGLYCAN FROM TISSUE CONTAINING BASAL MEMBRANE
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
US4945086A (en) * 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
JPH02156898A (en) * 1988-12-08 1990-06-15 Seikagaku Kogyo Co Ltd Anti-low density-type heparan sulfate proteoglycan monoclonal antibody, hybridoma producing the same and detection of low density-type heparan sulfate proteoglycan using the monoclonal antibody
WO1990007712A1 (en) * 1988-12-23 1990-07-12 Bissendorf Peptide Gmbh Antigen associated with degenerative diseases of the central nervous system (cns), antibody which reacts with said antigen and method for diagnosing dysfunctions of the cns
WO1990012033A1 (en) * 1989-03-29 1990-10-18 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US5310653A (en) * 1989-10-24 1994-05-10 Board Of Regents, The University Of Texas System Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis
RU2018835C1 (en) * 1990-11-11 1994-08-30 Гаркави Любовь Хаимовна Method of prognosis of oncologic disease course
AU2561792A (en) * 1991-09-06 1993-04-05 Children's Medical Center Corporation Cell-type specific heparan sulfate proteoglycans and their uses
RU2093832C1 (en) * 1993-08-31 1997-10-20 Владимир Михайлович Евстропов Method of immunological diagnosis of malignant neoplasm

Similar Documents

Publication Publication Date Title
RU93051783A (en) METHOD OF DETECTION OF IMPROVEMENT
ES516207A0 (en) "A METHOD OF DETECTING THE PRESENCE OF BIOLOGICAL AGENTS IN A LIQUID SAMPLE".
RU93048463A (en) DEVICE FOR IMAGE PROCESSING, DEVICE AND METHOD FOR DETERMINING LINEAR IMAGE SHIFT
DE69021638D1 (en) Sensor arrangement for measuring substances in liquids.
DE68919394D1 (en) System for detecting a biological object and fingerprint comparison system using this system.
IT1134863B (en) METHOD AND DEVICE FOR DETERMINING IN PARTICULAR THE QUANTITY OF ORGANIC CARBON CONTAINED IN A SAMPLE
ZA92271B (en) Detection of syndecan content in biological materials
DE68905313D1 (en) ENZYME IMMUNOASSAY FOR MEASURING CYCLOSPORIN-A MIRRORS IN WHOLE BLOOD SAMPLES.
AU7626787A (en) Method of detecting or estimating biological material
IL93331A0 (en) Type platelet-derived growth factor receptor gene
SE9101735D0 (en) METHOD AND SENSOR MEANS FOR DETERMINING MYOCARDIAL INFARCTION MARKERS
EP0656424A3 (en) Assay to determine the sensitivity to activated protein C.
FR2674254B1 (en) NON-RADIOACTIVE DETECTION OF THE PRESENCE OF A DETERMINED NUCLEIC ACID IN A BIOLOGICAL SAMPLE.
DE69121861D1 (en) PEPTIDES FROM SM-D-ANTIGEN, THEIR USE FOR DETECTING DISSEMINATED LUPUS ERYTHEMATEUX
FR2684110B1 (en) MICROBIOLOGICAL ANALYSIS METHOD AND MEDIUM FOR DETECTING YEASTS OF THE CANDIDA ALBICANS SPECIES.
RU96111676A (en) METHOD FOR EVALUATING AN IMMUNOLOGICAL REACTIVITY OF AN ORGANISM
EP1023604A4 (en) METHOD FOR LOCATING AND DETERMINING A SUBSTANCE IN A BIOLOGICAL SAMPLE
OA09402A (en) A method for the collection of antibodies and the detection of a specific antibody species in a fluid sample and a device for carrying out said method as well as a kit comprising said device.
IL98466A0 (en) Method for the qualitative and quantitative determination of polypeptides and proteins in solutions and biological fluids
RU96108150A (en) METHOD FOR DETERMINING THE BLOOD TOXICITY OF FISH
RU96119723A (en) METHOD FOR T-DEPENDENT IMMUNO DEFICIENCY IDENTIFICATION
ATE148232T1 (en) METHOD FOR DETERMINING THYROGLOBULIN AND KIT FOR USE THEREOF
Neto et al. Method of Determining Grain Size in a Polished Section
Mikaelyan Extractive--Fluorometric Determination of Microquantities of Gold by the Basic Dye Rivanol
Cantrell Anatomy, diagenesis and geochemistry of a Middle Ordovician oolite shoal, Eastern Tennessee